Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure
- PMID: 14514660
- DOI: 10.1093/carcin/bgg180
Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure
Abstract
Peroxisome proliferator activated receptor(alpha) (PPARalpha) mediates the liver's responses to peroxisome proliferator compounds. These responses include induction of specific hepatic enzymes, peroxisome proliferation and hepatocyte proliferation. PPARalpha null mice, which lack receptor in all cells of the body, do not respond to peroxisome proliferators, indicating that hepatocellular proliferation and other responses require the presence of this receptor in at least some cells. To determine if PPARalpha is required specifically in hepatocytes for each response, we used hepatocyte transplantation to generate chimeric livers composed of PPARalpha null and positive hepatocytes in PPARalpha null or positive hosts. Upon exposure to a peroxisome proliferator, peroxisome proliferation and enzyme induction were restricted to receptor positive hepatocytes, indicating that these responses are cell autonomous with respect to hepatocyte receptor status. However, both PPARalpha null and positive hepatocytes in chimeric livers displayed elevated DNA synthesis regardless of host receptor status, as long as at least some hepatocytes contained receptor. These findings indicate that the mitogenic response to peroxisome proliferators does not require PPARalpha in all hepatocytes.
Similar articles
-
Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.Cancer Res. 2004 Jun 1;64(11):3849-54. doi: 10.1158/0008-5472.CAN-04-0322. Cancer Res. 2004. PMID: 15172993
-
Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.Cancer Res. 2003 Sep 15;63(18):5767-80. Cancer Res. 2003. PMID: 14522898
-
Peroxisome proliferator-activated receptor-alpha mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor.Hepatology. 2001 Aug;34(2):262-6. doi: 10.1053/jhep.2001.26172. Hepatology. 2001. PMID: 11481610
-
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. doi: 10.1006/rtph.1999.1296. Regul Toxicol Pharmacol. 1999. PMID: 10388618 Review.
-
Regulation of cell proliferation and cell death by peroxisome proliferators.Microsc Res Tech. 2003 Jun 1;61(2):179-84. doi: 10.1002/jemt.10327. Microsc Res Tech. 2003. PMID: 12740824 Review.
Cited by
-
The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.Arch Toxicol. 2018 Jan;92(1):83-119. doi: 10.1007/s00204-017-2094-7. Epub 2017 Dec 2. Arch Toxicol. 2018. PMID: 29197930 Free PMC article. Review.
-
Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate.Mutat Res. 2012 Apr-Jun;750(2):141-158. doi: 10.1016/j.mrrev.2011.12.004. Epub 2011 Dec 20. Mutat Res. 2012. PMID: 22198209 Free PMC article. Review.
-
Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.Crit Rev Toxicol. 2006 May;36(5):459-79. doi: 10.1080/10408440600779065. Crit Rev Toxicol. 2006. PMID: 16954067 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
